← FDA Drug Approvals (Drugs@FDA)
MITOMYCIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2023-10-30
Drug application
- FDA Application #
ANDA216732- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MITOMYCIN
- Generic name
- MITOMYCIN
- Active ingredients
- MITOMYCIN
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- EUGIA PHARMA
- Manufacturer
- BluePoint Laboratories
- First approval
- 2023-10-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown